Pro-Dex (PDEX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for November 21, 2024, at 9:30 AM PST in Irvine, California.
Shareholders can vote online, by mail, or in person, with materials available electronically or by request.
Voting matters and shareholder proposals
Election of seven directors is on the agenda, with all nominees recommended by the board.
Ratification of Moss Adams, LLP as independent auditor for fiscal year ending June 30, 2025.
Advisory vote on executive compensation for named executive officers.
Proxies may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Seven director nominees listed: Raymond E. Cabillot, Angelita R. Domingo, William J. Farrell III, David C. Hovda, Katrina M. K. Philp, Nicholas J. Swenson, Richard L. Van Kirk.
Latest events from Pro-Dex
- Strong sales, new products, and investment gains boosted earnings and cash flow.PDEX
Q2 202629 Jan 2026 - Shareholders to vote on director elections, auditor, executive pay, and equity plan extension.PDEX
Proxy Filing1 Dec 2025 - Shareholders to vote on board elections, auditor ratification, and executive pay amid record growth.PDEX
Proxy Filing1 Dec 2025 - Annual meeting seeks votes on directors, auditor, pay, and equity plan extension.PDEX
Proxy Filing1 Dec 2025 - Revenue and net income surged on strong device sales and investment gains, but margin fell.PDEX
Q1 202630 Oct 2025 - Revenue and profit surged on orthopedic product shipments, but inventory controls remain a risk.PDEX
Q2 202516 Oct 2025 - Revenue up 24% and net income quadrupled in fiscal 2025, with strong outlook for 2026.PDEX
Q4 20254 Sep 2025 - Net income rebounded to $2.5M on 25% sales growth and improved gross margin.PDEX
Q1 202513 Jun 2025 - Sales and operating income rose sharply in 2024, but net income dropped on investment losses.PDEX
Q4 202413 Jun 2025